UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Learn which credit cards offer the best rewards points and make informed choices to maximize your benefits. Start comparing today!
28,095 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A top, widely watched market researcher foresees NVIDIA delivering a robust earnings beat driven by data center stren...
As Alphabet shifts its advertising footprint and data strategy, Disney investors just really need to understand the p...
Broadcom’s AI-driven revenue surge is reshaping the chip landscape, prompting persistent buying from a longtime inves...
A private AI-focused XR company invites retail investors to participate in a sub-$1 pre-IPO round, offering bonus sha...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
The USDA has expanded a Trader Joe's recall to nearly pounds frozen fried rice, now covering close to 10 million poun...
DIY investing has transformed how households build wealth, but some life moments require outside help. This guide exp...
A private luncheon for the largest holders of a Trump-themed memecoin is back at Mar-a-Lago, renewing headlines about...
Across industries, firms are battling AI-generated junk that erodes trust online. The fight shapes ad budgets, conten...
Fidelity’s Active Large Growth ETF threads a narrow but meaningful edge over passive peers as AI-enabled demand fuels...
Three value-focused ETFs outperformed the broad market in 2026, each using a different approach to value. AVLV, AVUV,...